The nonpartisan scorekeeper’s new report reinforces longstanding concerns about the 340B drug discount program, including ...

Congress is considering a new bill that, in theory, would boost low-income patients’ - especially Latinos’ - access to ...

A bipartisan group of 163 lawmakers is urging the Department of Health and Human Services (HHS) to cancel an upcoming pilot ...

A bipartisan group of lawmakers has sent a letter to the Department of Health and Human Services, asking the agency to cancel ...

The American Hospital Association is calling on federal regulators to launch an antitrust investigation into its claims of drug manufacturers’ actions regarding 340B rebate models. In a letter sent to ...

The rapid growth of urban hospitals claiming “administratively rural” status within Medicare is yet another example of how ...

The American Hospital Association is asking the Federal Trade Commission and the Department of Justice to get involved in the ...

For-profit drug manufacturers want to change how the 340B Drug Pricing Program works, but going from upfront savings to back-end rebates will kill nonprofit health providers.

The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.